Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia

Clinical trial NCT07037836 · RECRUITING

Trial details

NCT number: NCT07037836
Sponsor: Bastiaan Driehuys
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

COPD (Chronic Obstructive Pulmonary Disease)Hypoxemia

Start date: 2025-09-29
Primary completion: 2027-07-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.